Literature DB >> 34066560

Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.

Laura Marinela Ailioaie1, Gerhard Litscher2.   

Abstract

In recent decades, researchers around the world have been studying intensively how micro-organisms that are present inside living organisms could affect the main processes of life, namely health and pathological conditions of mind or body. They discovered a relationship between the whole microbial colonization and the initiation and development of different medical disorders. Besides already known probiotics, novel products such as postbiotics and paraprobiotics have been developed in recent years to create new non-viable micro-organisms or bacterial-free extracts, which can provide benefits to the host with additional bioactivity to probiotics, but without the risk of side effects. The best alternatives in the use of probiotics and postbiotics to maintain the health of the intestinal microbiota and to prevent the attachment of pathogens to children and adults are highlighted and discussed as controversies and challenges. Updated knowledge of the molecular and cellular mechanisms involved in the balance between microbiota and immune system for the introspection on the gut-lung-brain axis could reveal the latest benefits and perspectives of applied photobiomics for health. Multiple interconditioning between photobiomodulation (PBM), probiotics, and the human microbiota, their effects on the human body, and their implications for the management of viral infectious diseases is essential. Coupled complex PBM and probiotic interventions can control the microbiome, improve the activity of the immune system, and save the lives of people with immune imbalances. There is an urgent need to seek and develop innovative treatments to successfully interact with the microbiota and the human immune system in the coronavirus crisis. In the near future, photobiomics and metabolomics should be applied innovatively in the SARS-CoV-2 crisis (to study and design new therapies for COVID-19 immediately), to discover how bacteria can help us through adequate energy biostimulation to combat this pandemic, so that we can find the key to the hidden code of communication between RNA viruses, bacteria, and our body.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; abscopal effect; gut; immune; infections; low-level laser; lung; microbiome; pro-, pre-, syn-, para-, and postbiotics

Year:  2021        PMID: 34066560      PMCID: PMC8124384          DOI: 10.3390/ijms22094942

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  271 in total

1.  Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum.

Authors:  I Santino; A Alari; S Bono; E Teti; M Marangi; A Bernardini; L Magrini; S Di Somma; A Teggi
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jan-Mar       Impact factor: 3.219

Review 2.  Immune adaptations that maintain homeostasis with the intestinal microbiota.

Authors:  Lora V Hooper; Andrew J Macpherson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

3.  Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.

Authors:  María Fernanda Landaburu; Gabriela A López Daneri; Silvia Relloso; Leandro Jorge Zarlenga; Mónica Alejandra Vinante; María Teresa Mujica
Journal:  Rev Argent Microbiol       Date:  2019-06-28       Impact factor: 1.852

Review 4.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 5.  Emerging knowledge of regulatory roles of D-amino acids in bacteria.

Authors:  Felipe Cava; Hubert Lam; Miguel A de Pedro; Matthew K Waldor
Journal:  Cell Mol Life Sci       Date:  2010-12-14       Impact factor: 9.261

Review 6.  Probiotics to counteract biofilm-associated infections: promising and conflicting data.

Authors:  Claudia Vuotto; Francesca Longo; Gianfranco Donelli
Journal:  Int J Oral Sci       Date:  2014-09-26       Impact factor: 6.344

Review 7.  Protective Microbiota: From Localized to Long-Reaching Co-Immunity.

Authors:  Lynn Chiu; Thomas Bazin; Marie-Elise Truchetet; Thierry Schaeverbeke; Laurence Delhaes; Thomas Pradeu
Journal:  Front Immunol       Date:  2017-12-07       Impact factor: 7.561

Review 8.  Gut microbiota of the very-low-birth-weight infant.

Authors:  Sharon Unger; Alain Stintzi; Prakeshkumar Shah; David Mack; Deborah L O'Connor
Journal:  Pediatr Res       Date:  2014-10-13       Impact factor: 3.756

9.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Infect Dis       Date:  2018-09-19       Impact factor: 25.071

Review 10.  Paraprobiotics and Postbiotics of Probiotic Lactobacilli, Their Positive Effects on the Host and Action Mechanisms: A Review.

Authors:  Tsegay Teame; Anran Wang; Mingxu Xie; Zhen Zhang; Yalin Yang; Qianwen Ding; Chenchen Gao; Rolf Erik Olsen; Chao Ran; Zhigang Zhou
Journal:  Front Nutr       Date:  2020-10-22
View more
  6 in total

Review 1.  Parkinson's Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment.

Authors:  Aurelian Anghelescu; Gelu Onose; Cristina Popescu; Mihai Băilă; Simona Isabelle Stoica; Ruxandra Postoiu; Elena Brumă; Irina Raluca Petcu; Vlad Ciobanu; Constantin Munteanu
Journal:  Biomedicines       Date:  2022-04-26

Review 2.  The Concept of Intrauterine Programming and the Development of the Neonatal Microbiome in the Prevention of SARS-CoV-2 Infection.

Authors:  Martina Grot; Karolina Krupa-Kotara; Agata Wypych-Ślusarska; Mateusz Grajek; Agnieszka Białek-Dratwa
Journal:  Nutrients       Date:  2022-04-20       Impact factor: 6.706

3.  In Vitro Study of Probiotic, Antioxidant and Anti-Inflammatory Activities among Indigenous Saccharomyces cerevisiae Strains.

Authors:  Gabriella Siesto; Rocchina Pietrafesa; Vittoria Infantino; Channmuny Thanh; Ilaria Pappalardo; Patrizia Romano; Angela Capece
Journal:  Foods       Date:  2022-05-05

Review 4.  Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review.

Authors:  Douglas Xavier-Santos; Marina Padilha; Giovanna Alexandre Fabiano; Gabriel Vinderola; Adriano Gomes Cruz; Katia Sivieri; Adriane Elisabete Costa Antunes
Journal:  Trends Food Sci Technol       Date:  2022-01-02       Impact factor: 12.563

Review 5.  A Narrative Review on Oral and Periodontal Bacteria Microbiota Photobiomodulation, through Visible and Near-Infrared Light: From the Origins to Modern Therapies.

Authors:  Andrea Amaroli; Silvia Ravera; Angelina Zekiy; Stefano Benedicenti; Claudio Pasquale
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

Review 6.  The Biotics Family: Current Knowledge and Future Perspectives in Metabolic Diseases.

Authors:  Codrina-Madalina Palade; Georgiana-Anca Vulpoi; Radu-Alexandru Vulpoi; Vasile Liviu Drug; Oana-Bogdana Barboi; Manuela Ciocoiu
Journal:  Life (Basel)       Date:  2022-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.